Ribbon Communications Inc (RBBN) News

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

U.S. FDA Renews DILIsym® Software Licenses for 7th Year

Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals Simulations Plus, Inc. (Nasdaq: SLP), a leading...

Exxon Mobil Forecasts Earnings Decline, Twilio Seeks Board Tenure Changes, and More News

Exxon Mobil (NYSE:XOM) – Exxon Mobil predicted a drop in first-quarter operating results due to lower...

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Total revenue of $18.3 million and diluted earnings per share (EPS) of $0.20 Maintains full-year revenue guidance of $66 to $69 million (+10-15...

U.S. Futures Dip in Pre-Market, May WTI and June Brent Crude Prices Edge Higher

U.S. index futures are slightly down in pre-market trading this Wednesday, reflecting the continuation of a...

Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date

Conference call to be on Wednesday, April 3, 2024, at 5 p.m. EDT Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that...

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Simulations Plus and the University of Bath Awarded New FDA Grant

Partnership will produce an enhanced, validated dermal PBBM/PBPK model to inform product development and bioequivalence decisions Simulations...